For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Liraglutide - Weight management in adults
PAD Profile : Liraglutide - Weight management in adults
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
Additional Documents
Committee Recommendations
A Medicines Shortage Notification has been issued in relation to the supply shortages of GLP-1s.
See GLP-1 Medicine Shortage document below for full details
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) have approved:
- the updated guidance for the Management of Obesity in Adults
- Liraglutide (Saxenda) referral criteria and pathway
See documents below
The APC recommends the use of liraglutide (prescribed as Saxenda) as an option for managing overweight and obese patients in line with NICE TA664 (see link to NICE below).
Liraglutide (Saxenda) will be considered RED on the traffic light system.
Weight management local guidance will be updated and referreal criteria to be developed with ASPH